"the thought (yours, apparently) now is that NNVC did/does NOT pay for Theracour employees to develop the drugs? "
Of course they do.
"Theracour is hiring people and figuring out how to manufacture nanoviricides on their own dime and not being reimbursed by NNVC for said work?"
Again, something I never said (and a declarative sentence with a question mark on the end of it doesn't really turn it into a question?).
"I honestly don't know the answer to who would own the IP related to drug production if NNVC paid Theracour to do the work on their behalf as part of the contract / license."
I do and I think I said so. TheraCour.
If I missed the language in the agreements that indicated that all of TheraCour developed IP is automatically conveyed to NNVC I hereby apologize, but I'm not sure that I did. Feel free to point it out.
There is zero question that NNVC is paying TheraCour to do what they do. However it is my understanding that employees who develop products and processes for pay automatically assign the rights to that IP to their employer...I'm guessing that they can agree to do otherwise in their employment contracts but we don't have any information to suggest that. They are TheraCour employees (by AD's design). Do you wonder why at all?
At the risk of complicating the issue...and I should probably just wait until the above is either acknowledged or refuted but I can't...another related issue needs examining:
Given his multiple hats and evidently multiple employers, who owns any IP that Anil Diwan himself might develop?
I can't help this either (for Mike)....Will the room he's in when he does the developing have a bearing on the answer?
"Successful commercialization is succeeding in the process of
commercializing. It is not successfully having commercialized."
Say what?
